Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
about
Therapeutic interventions for Burkitt lymphoma in childrenInterventions for previously untreated patients with AIDS-associated Non-Hodgkin´s LymphomaHow I treat HIV-associated lymphomaUpdated consensus statement on the use of rituximab in patients with rheumatoid arthritis.Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium.Quality of life, characteristics and survival of patients with HIV and lymphoma.Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapyHIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL).Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.Consensus statement on the use of rituximab in patients with rheumatoid arthritisAIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral TherapyPooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphomaMalignancies in HIV/AIDS: from epidemiology to therapeutic challenges.Hematopoietic stem cell transplantation for AIDS-related malignanciesModern management of non-Hodgkin lymphoma in HIV-infected patients.Rituximab therapy in malignant lymphoma.The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection.Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.Clinical Analysis of Five Cases of AIDS-related Non-Hodgkin Lymphoma.Immunotherapy for HIV-associated non-Hodgkin's lymphoma.Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.Cancer in cohort of HIV-infected population: prevalence and clinical characteristics.Therapeutic options for HIV-associated lymphomas.Eleven years of experience with AIDS-related lymphomas at the Institute of Oncology Ljubljana.Infections associated with monoclonal antibody and fusion protein therapy in humans.Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).Clinical management of HIV-associated hematologic malignancies.Ongoing change in the treatment of HIV-associated malignancies in the HAART era.Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell LymphomaHead and Neck Lymphomas in HIV Patients: a Clinical Perspective.Rituximab in the treatment of non-Hodgkin's lymphomaRaltegravir-based HAART regimen in a patient with large B-cell lymphoma.A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphoma.The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.
P2860
Q24235495-8F9535DB-5EB8-467B-BF5A-486D1B92E251Q24240190-110224A5-FA42-43E6-A840-40BE0798325DQ26821860-35492F82-5FE1-43A4-AD29-5E0833FDB9CCQ27691388-14E53098-8595-4AD9-9CBD-62F559A9CBA7Q33401481-0E999379-A638-4256-8C2B-B5FEE646BB0CQ33629332-EE3A8405-6244-44A6-926F-7CDE15499FD2Q33651611-FD6B562F-CBBA-4CB4-8AEF-5F2801304582Q33767818-54FFC00F-1C00-4B91-8003-0067052590E1Q33806007-63A9FA0E-0A86-4D74-9DA2-65A2F298E7DCQ33952616-4E122120-7B81-443A-8630-651E06953D5FQ34047901-FD2FAA77-133B-4F77-A7CF-063FA8932F85Q35583973-8E1970CF-03AC-4B57-A9BA-838F88700F2BQ35606384-703BDB15-7955-4EFE-BAE5-D8518BB2F4AAQ35638676-EFAA1DCC-E97D-4C3F-8A80-BA18889D71FAQ35779619-7E9634AD-6634-44F7-B901-ADF08D0A0662Q35848330-7E2A0F71-ABDC-46F1-8907-D9CCFC71D3E2Q35850380-F09FF76D-E144-4F72-B080-A6E8FAF869EAQ36510026-EA48A456-3134-49E4-917A-0DE331033CF0Q36710347-82B8AFE5-C2F8-4CB3-98BE-D747FCC7E312Q36832102-9DA0B069-9CD0-4E8D-B916-4F443ED982B1Q36956149-A273AD5F-265C-4661-A22A-F8710FDAF553Q37106782-85533A50-93C0-48E3-9C3E-825AFF2EDCAFQ37291598-88C710D4-7CA5-4F84-B113-022C82374C4BQ37563265-9E21C3BA-1AFF-4904-8D29-8AAF030C83E8Q37567836-B839E3F6-4DE4-4006-AB28-08E2F236000BQ37572815-F9EEC242-F13B-4B12-9E03-9B8F797A78BCQ37763574-8F589617-F3AB-4AE0-909A-4C29D5977CDCQ37781368-E2B6A3F9-DC03-4C6C-9DC3-02CF0B1FB380Q37868477-A6847AEB-5749-4847-96FA-820DAD9D61DBQ37912944-18AEF2D5-0B9D-4F7D-A2F8-B3C446FA4141Q38194845-264AE145-AE20-4C42-9FEF-89859BF63F10Q38210131-EE06AE9B-C6B8-4C19-9EF5-1F1170042496Q38664912-64E65BE9-D851-42CC-975C-052BB4356DCDQ39207881-F95650E0-9A29-40CE-8761-2649BEF76DB1Q41678875-F3F8F9E7-0ACB-46F2-B0CB-82F0B028F3B8Q41919568-9D30AA03-821B-4965-9835-64E431D2D322Q41925899-04D9AF50-B122-462C-95DF-B914D2ACC687Q43205348-F5C0FB3F-AFE3-48D3-A03D-E525178A5DC4Q43752446-1E215D30-3F40-4345-84A5-E9718C938AEFQ47563526-22CFA9A1-019B-4768-88EE-864545105140
P2860
Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.
@ast
Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.
@en
type
label
Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.
@ast
Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.
@en
prefLabel
Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.
@ast
Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.
@en
P2093
P356
P1476
Phase II trial of CHOP plus ri ...... ciated non-Hodgkin's lymphoma.
@en
P2093
Antoine Cheret
Christian Gisselbrecht
Eric Billaud
Fabrice Bonnet
François Boué
Jacques Reynes
Jean Gabarre
Martine Raphael
Remi Lancar
P304
P356
10.1200/JCO.2005.05.4684
P407
P577
2006-08-08T00:00:00Z